Skip to main content

Leading Operational Excellence in a Global Company

  • Chapter
  • First Online:
  • 3035 Accesses

Abstract

Most pharmaceutical companies have introduced Operational Excellence (OPEX) programs to optimize quality, costs, and time. Many of those responsible for OPEX have tried to identify the key factors leading to a successful implementation of OPEX. Identifying these factors is especially interesting against the backdrop that more than a few OPEX programs fail during implementation. This article reflects on the importance of leadership at company and individual level for the successful implementation of OPEX programs.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark McColgan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McColgan, M. (2013). Leading Operational Excellence in a Global Company. In: Friedli, T., Basu, P., Bellm, D., Werani, J. (eds) Leading Pharmaceutical Operational Excellence. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35161-7_26

Download citation

Publish with us

Policies and ethics